Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer-Reference-Cited by-同舟云学术

Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer

Published:2021-05 Issue: Volume:155 Page:34-39
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Moraes Fabio Y.^ORCID,Mansouri Alireza,Dasgupta Archya^ORCID,Ramotar Matthew,Kosyak Natalya,Weiss Jessica,Laperriere Normand,Millar Barbara-Ann,Berlin Alejandro,Conrad Tatiana,van Prooijen Monique^ORCID,Heaton Robert,Coolens Catherine,Winter Jeff^ORCID,Bernstein Mark^ORCID,Zadeh Gelareh,Kongkham Paul,Doherty Mark,Shultz David B.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J. Natl. Cancer Inst.,2005

2. EGFR mutation and brain metastasis in pulmonary adenocarcinomas;Shin;J. Thorac. Oncol. Off. Publ. Int. Assoc. Stud. Lung Cancer,2014

3. EGFR TKIs plus WBRT demonstrated No survival benefit other than that of TKIs alone in patients with NSCLC and EGFR mutation and brain metastases;Jiang;J. Thorac. Oncol. Off. Publ. Int. Assoc. Stud. Lung Cancer,2016

4. EGFR mutation status on brain metastases from non-small cell lung cancer;Hsu;Lung Cancer Amst. Neth.,2016

5. Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer;Li;J. Thorac. Dis.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer;Lung Cancer;2024-05

2. Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review;Advances in Therapy;2024-03-21

3. Clinical Results and Hematologic Predictors of Linear Accelerator–Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study;World Neurosurgery;2024-03

4. Stereotactic body radiation therapy for spinal metastases: A new standard of care;Neuro-Oncology;2024-03-01

5. Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor;European Journal of Pharmacology;2023-04